Clinical trial
MOVIPREP® Versus NaP Pivotal Phase III Study
NCT00322062 · Norgine, Industry · Completed
Key facts
| NCT number | NCT00322062 |
|---|---|
| Title | MOVIPREP® Versus NaP Pivotal Phase III Study |
| Official title | A Prospective Randomised Single-Blinded Multicentric and Pivotal Phase III Study Comparing the Efficacy, Safety and Acceptability of a New 2 Litres Gut Lavage Solution NRL994 Versus a Sodium Phosphate Solution for Colonoscopy Preparation |
| Lead sponsor | Norgine, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Colonoscopy |
| Intervention type | Drug |
| Interventions | macrogol3350 NA sulphate NACL KCL ascorbic acid NA ascorbate, Sodium Phosphate Solution |
| Enrollment | 340 |
| Start date | Apr 1, 2002 |
| Completion | Mar 1, 2003 |
| First posted | May 4, 2006 |
| Last update posted | Apr 16, 2008 |
| Countries | France |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: